BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 12374204)

  • 1. Complex gangliosides as autoantibody targets at the neuromuscular junction in Miller Fisher syndrome: a current perspective.
    O'Hanlon GM; Bullens RW; Plomp JJ; Willison HJ
    Neurochem Res; 2002 Aug; 27(7-8):697-709. PubMed ID: 12374204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concanavalin A inhibits pathophysiological effects of anti-ganglioside GQ1b antibodies at the mouse neuromuscular synapse.
    Bullens RW; Halstead SK; O'Hanlon GM; Veitch J; Molenaar PC; Willison HJ; Plomp JJ
    Muscle Nerve; 2005 Jun; 31(6):751-60. PubMed ID: 15793847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-GQ1b ganglioside antibodies mediate complement-dependent destruction of the motor nerve terminal.
    O'Hanlon GM; Plomp JJ; Chakrabarti M; Morrison I; Wagner ER; Goodyear CS; Yin X; Trapp BD; Conner J; Molenaar PC; Stewart S; Rowan EG; Willison HJ
    Brain; 2001 May; 124(Pt 5):893-906. PubMed ID: 11335692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired neuromuscular junction transmission in anti-GQ1b antibody negative Miller Fisher variant.
    Chan YC; Rathakrishnan R; Chan BP
    Clin Neurol Neurosurg; 2006 Oct; 108(7):717-8. PubMed ID: 16337336
    [No Abstract]   [Full Text] [Related]  

  • 5. Miller Fisher syndrome with presynaptic neuromuscular transmission disorder.
    Ehler E; Latta J
    J Clin Neurosci; 2014 Nov; 21(11):2025-7. PubMed ID: 25300589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model.
    Halstead SK; Zitman FM; Humphreys PD; Greenshields K; Verschuuren JJ; Jacobs BC; Rother RP; Plomp JJ; Willison HJ
    Brain; 2008 May; 131(Pt 5):1197-208. PubMed ID: 18184663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and immunological spectrum of the Miller Fisher syndrome.
    Lo YL
    Muscle Nerve; 2007 Nov; 36(5):615-27. PubMed ID: 17657801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double agents and breakdown of integrity at the neuromuscular junction in Miller-Fisher syndrome.
    Slater C
    Brain; 2001 May; 124(Pt 5):847-8. PubMed ID: 11335689
    [No Abstract]   [Full Text] [Related]  

  • 9. A case of Miller Fisher syndrome with anti GQ1b in Thailand.
    Sawanyawisuth K; Tiamkao S; Jitpimolmard S; Vincent A
    J Med Assoc Thai; 2007 Feb; 90(2):391-3. PubMed ID: 17375649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presynaptic neuromuscular transmission defect in the Miller Fisher syndrome.
    Lo YL; Leoh TH; Dan YF; Lim LL; Seah A; Fook-Chong S; Ratnagopal P
    Neurology; 2006 Jan; 66(1):148-9. PubMed ID: 16401873
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ataxia with ophthalmoplegia: Miller-Fisher syndrome with anti-GQ1b antibody positivity].
    Guilloton L; Camarasa C; Agard E; Tondeur G; Dot C; Drouet A
    J Fr Ophtalmol; 2014 Feb; 37(2):89-92. PubMed ID: 24513384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulins inhibit pathophysiological effects of anti-GQ1b-positive sera at motor nerve terminals through inhibition of antibody binding.
    Jacobs BC; O'Hanlon GM; Bullens RW; Veitch J; Plomp JJ; Willison HJ
    Brain; 2003 Oct; 126(Pt 10):2220-34. PubMed ID: 12876146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiological evidence by single fibre electromyography of neuromuscular transmission impairment in a case of Miller Fisher syndrome.
    Sartucci F; Cafforio G; Borghetti D; Domenici L; Orlandi G; Murri L
    Neurol Sci; 2005 Jun; 26(2):125-8. PubMed ID: 15995829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathophysiology of Ataxia in Fisher Syndrome].
    Kuwabara S
    Brain Nerve; 2016 Dec; 68(12):1411-1414. PubMed ID: 27916750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent developments in Miller Fisher syndrome and related disorders.
    Overell JR; Willison HJ
    Curr Opin Neurol; 2005 Oct; 18(5):562-6. PubMed ID: 16155441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-GQ1b antibody does not affect neuromuscular transmission in human limb muscle.
    Kuwabara S; Misawa S; Takahashi H; Sawai S; Kanai K; Nakata M; Mori M; Hattori T; Yuki N
    J Neuroimmunol; 2007 Sep; 189(1-2):158-62. PubMed ID: 17673301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunopathogenesis of Miller Fisher syndrome.
    Willison HJ; O'Hanlon GM
    J Neuroimmunol; 1999 Dec; 100(1-2):3-12. PubMed ID: 10695710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-GQ1b syndrome. A child with Miller-Fisher-Bickerstaff syndrome].
    Amadi MA; Orlandi M; Pérez FE; Goldaracena PX; Brogiolo O; Almonacid García EY
    Arch Argent Pediatr; 2020 Jun; 118(3):e333-e337. PubMed ID: 32470277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical spectrum of the anti-GQ1b antibody syndrome: a case series of eight patients.
    de Bruyn A; Poesen K; Bossuyt X; Heremans IP; Claeys T; Depuydt CE; Van Damme P; Claeys KG
    Acta Neurol Belg; 2019 Mar; 119(1):29-36. PubMed ID: 30747336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recurrent Miller Fisher syndrome and anti-GQ1b antibodies].
    Riche G; Caudie C; Vial C; Bourrat C
    Rev Med Interne; 1998 Mar; 19(3):192-5. PubMed ID: 9775140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.